Percuflex Plus Ureteral Stent Set 6FX26CM with .038 Sensor UPN: M006175263110

FDA Device Recall #Z-1734-2020 — Class II — March 9, 2020

Recall Summary

Recall Number Z-1734-2020
Classification Class II — Moderate risk
Date Initiated March 9, 2020
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Boston Scientific
Location Marlborough, MA
Product Type Devices
Quantity 32

Product Description

Percuflex Plus Ureteral Stent Set 6FX26CM with .038 Sensor UPN: M006175263110

Reason for Recall

An increase in the rate of complaints for difficulty or inability to track over the guidewire, may result in a procedural delay due to the need to exchange the affected device

Distribution Pattern

Nationwide Foreign: Europe, Middle East and Africa, the Americas (North America and South America, Asia Pacific and Japan

Lot / Code Information

Lot Number: 24835477 (edited 1/13/2021)

Other Recalls from Boston Scientific

Recall # Classification Product Date
Z-1740-2020 Class II Polaris Ultra Ureteral Stent Set 6FX24CM with .... Mar 9, 2020
Z-1732-2020 Class II Sensor Nitinol Wire with Hydrophilic Tip .0383C... Mar 9, 2020
Z-1730-2020 Class II Sensor Nitinol Wire with Hydrophilic Tip .035 3... Mar 9, 2020
Z-1738-2020 Class II Stretch VL Ureteral Stent Set 6FX22- 30CM with ... Mar 9, 2020
Z-1731-2020 Class II Sensor Nitinol Wire with Hydrophilic Tip .038 3... Mar 9, 2020

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.